MRP1/ABCC1 Cancer Research Results

MRP1/ABCC1, Multidrug Resistance Protein 1: Click to Expand ⟱
Source:
Type:
Multidrug resistance protein 1 (MRP1) encoded by ABCC1 gene.
MRP1 levels are elevated in numerous cancer types, NSCLC, breast cancer, and prostate cancer Multidrug Resistance Protein 1 (MDR1), also known as P-glycoprotein (P-gp) or ABCB1, is a membrane protein that functions as an efflux pump, transporting a variety of drugs and xenobiotics out of cells. Its expression is a significant factor in the development of multidrug resistance (MDR) in cancer therapy.

Resistance Protein 1 (MDR1) is often upregulated in various cancers, and its high expression is associated with poor prognosis and protumorigenic effects due to its role in drug resistance.
Field Suggested Entry
Target ABCC1 / MRP1
Full Name ATP-binding cassette subfamily C member 1 / multidrug resistance-associated protein 1
Target Class ATP-dependent ABC efflux transporter
Primary Biology Efflux of drugs, xenobiotics, organic anions, glutathione conjugates, oxidized glutathione, and inflammatory lipid mediators
Cancer Relevance High: contributes to multidrug resistance by exporting anticancer drugs and reducing intracellular drug accumulation
AD Relevance Medium: possible role in amyloid-β clearance and barrier transporter function, but less established than ABCB1/P-gp and LRP1
Therapeutic Direction Context-dependent. In cancer, inhibition/down-modulation may improve chemotherapy retention in tumor cells. In AD, support/upregulation may be desirable if enhancing amyloid-β clearance. Systemic inhibition may increase normal-tissue toxicity.


Scientific Papers found: Click to Expand⟱
8874- MOR,    The anticarcinogenic and anticancer effects of the dietary flavonoid, morin: Current status, challenges, and future perspectives
- Review, Var, NA
AntiCan↑, selectivity↑, *ROS↓, *Inflam↓, *p‑Akt↓, *NF-kB↓, ChemoSen↑, chemoPv↑, *toxicity↓, BioAv↑, BioAv↓, MRP1/ABCC1↝, BioAv↑, PCNA↓, hepatoP↑, NF-kB↓, TNF-α↓, IL6↓, PGE2↓, MMP2↓, MMP9↓, Apoptosis↑, TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, DR5↑, FasL↑, FADD↑, ROS↑, MMP↓, BAX↑, Bcl-xL↓, Casp9↑, Casp3↑, EMT↓, Akt↓, Hippo↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

ROS↑, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↑, 1,   BAX↑, 1,   Bcl-xL↓, 1,   Casp3↑, 1,   Casp9↑, 1,   DR5↑, 1,   FADD↑, 1,   FasL↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 1,   Hippo↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

PCNA↓, 1,  

Migration(tgid=13) ⓘ

EMT↓, 1,   MMP2↓, 1,   MMP9↓, 1,  

Barriers & Transport(tgid=15) ⓘ

MMP↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

IL6↓, 1,   NF-kB↓, 1,   PGE2↓, 1,   TNF-α↓, 1,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 1,   BioAv↑, 2,   ChemoSen↑, 1,   MRP1/ABCC1↝, 1,   selectivity↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

IL6↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 1,   chemoPv↑, 1,   hepatoP↑, 1,  
Total Targets: 30

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

ROS↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

p‑Akt↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

Inflam↓, 1,   NF-kB↓, 1,  

Functional Outcomes(tgid=23) ⓘ

toxicity↓, 1,  
Total Targets: 5

Scientific Paper Hit Count for: MRP1/ABCC1, Multidrug Resistance Protein 1
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:0  prod#:%  Target#:424  State#:%  Dir#:4
  wNotes=0  sortOrder:rid,rpid

 

Home Page